Quarry LP’s IGM Biosciences IGMS Stock Holding History

Quarry LP’s Portfolio IGMS Stock Details IGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-197	Closed	-$1.35K	–	1851
2024 Q2	$1.35K	Buy	+197	New	+$1.69K	﹤0.01%	1673

Other funds holding IGMS

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quarry LP's IGMS Position: Q3 2024 in Review

Quarry LP sold out of IGM Biosciences (IGMS) in Q3 2024, closing a stake of 197 shares — an estimated $1.35K sold.

Quarry LP first reported a position in IGMS in Q2 2024 and held it in 1 quarter. The position peaked at $1.35K in Q2 2024. 72 funds tracked by Wall St. Rank hold IGMS as of Q3 2024.

Quarry LP reported no remaining IGM Biosciences position as of Q3 2024 after selling out during the quarter.
Quarry LP sold 197 IGM Biosciences shares in Q3 2024, an estimated $1.35K.
Quarry LP first reported a position in IGM Biosciences in Q2 2024 and held it in 1 quarter.
Quarry LP's IGM Biosciences position peaked at $1.35K in Q2 2024.
72 funds tracked by Wall St. Rank held IGM Biosciences as of Q3 2024.

Based on Quarry LP's 13F filing for Q3 2024, filed 14 Nov 2024.